Home LiteratureArticle Details
PMID: 16163533 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Abnormal frontal activations related to decision-making in current and former amphetamine and opiate dependent individuals.

Psychopharmacology ·Vol. 180 ·No. 4 ·2005-08-00 ·Pages 612-23

Ersche KD, Fletcher PC, Lewis SJ, Clark L, Stocks-Gee G, London M, Deakin JB, Robbins TW, Sahakian BJ

Abstract

There is converging evidence for impairments in decision-making in chronic substance users. In the light of findings that substance abuse is associated with disruptions of the functioning of the striato-thalamo-orbitofrontal circuits, it has been suggested that decision-making impairments are linked to frontal lobe dysfunction. We sought to investigate this possibility using functional neuroimaging. Decision-making was investigated using the Cambridge Risk Task during H2(15)O PET scans. A specific feature of the Risk Task is the decisional conflict between an unlikely high reward option and a likely low reward option. Four groups, each consisting of 15 participants, were compared: chronic amphetamine users, chronic opiate users, ex-drug users who had been long-term amphetamine/opiate users but are abstinent from all drugs of abuse for at least 1 year and healthy matched controls without a drug-taking history. During decision-making, control participants showed relatively greater activation in the right dorsolateral prefrontal cortex, whereas participants engaged in current or previous drug use showed relatively greater activation in the left orbitofrontal cortex. Our results indicate a disturbance in the mediation by the prefrontal cortex of a risky decision-making task associated with amphetamine and opiate abuse. Moreover, this disturbance was observed in a group of former drug users who had been abstinent for at least 1 year.

MeSH Terms
Adult Age of Onset Amphetamine-Related Disorders/pathology,physiopathology Analysis of Variance Brain Mapping Decision Making/physiology Female Humans Male Memory, Short-Term/drug effects,physiology Middle Aged Neuropsychological Tests/statistics & numerical data Opioid-Related Disorders/pathology,physiopathology Positron-Emission Tomography/methods Prefrontal Cortex/pathology,physiopathology Psychomotor Performance/drug effects,physiology Time Factors
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Ersche K D
Department of Psychiatry, School of Clinical Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK. [email protected]
Fletcher P C
Lewis S J G
Clark L
Stocks-Gee G
London M
Deakin J B
Robbins T W
Sahakian B J
References (58)
58 references, click to expand
  1. Incentive-sensitization and addiction.
    Addiction. 2001 Jan;96(1):103-14 PMID: 11177523
  2. Frontal activations associated with accessing and evaluating information in working memory: an fMRI study.
    Neuroimage. 2003 Nov;20(3):1531-9 PMID: 14642465
  3. Decision-making and addiction (part II): myopia for the future or hypersensitivity to reward?
    Neuropsychologia. 2002;40(10):1690-705 PMID: 11992657
  4. Prefrontal-subcortical dissociations underlying inhibitory control revealed by event-related fMRI.
    Eur J Neurosci. 2004 Jun;19(11):3105-12 PMID: 15182319
  5. Dissociating valence of outcome from behavioral control in human orbital and ventral prefrontal cortices.
    J Neurosci. 2003 Aug 27;23(21):7931-9 PMID: 12944524
  6. Decision-making deficits in drug addiction.
    Trends Cogn Sci. 2002 Sep 1;6(9):361 PMID: 12200169
  7. Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers.
    Neuropsychologia. 2001;39(4):376-89 PMID: 11164876
  8. Risk of job-related injury among construction laborers with a diagnosis of substance abuse.
    J Occup Environ Med. 1998 Jun;40(6):573-7 PMID: 9636939
  9. The relevance of behavioural measures for functional-imaging studies of cognition.
    Nat Rev Neurosci. 2004 Jan;5(1):67-73 PMID: 14708005
  10. Functional MRI studies of spatial and nonspatial working memory.
    Brain Res Cogn Brain Res. 1998 Jul;7(1):1-13 PMID: 9714705
  11. Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers.
    Neuropsychopharmacology. 2000 Aug;23(2):113-26 PMID: 10882838
  12. Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence.
    Am J Psychiatry. 2004 Feb;161(2):242-8 PMID: 14754772
  13. Frontal lobes and human memory: insights from functional neuroimaging.
    Brain. 2001 May;124(Pt 5):849-81 PMID: 11335690
  14. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers.
    Synapse. 1993 Jun;14(2):169-77 PMID: 8101394
  15. Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task.
    Neuroimage. 2003 Jul;19(3):1085-94 PMID: 12880834
  16. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets.
    Neuroimage. 2003 Jul;19(3):1233-9 PMID: 12880848
  17. Illicit drugs and driving: prevalence, beliefs and accident involvement among a cohort of current out-of-treatment drug users.
    Drug Alcohol Depend. 2000 Feb 1;58(1-2):197-204 PMID: 10669072
  18. The orbitofrontal cortex in methamphetamine addiction: involvement in fear.
    Neuroreport. 2002 Dec 3;13(17):2253-7 PMID: 12488806
  19. Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal.
    Neuropsychopharmacology. 1997 Feb;16(2):174-82 PMID: 9015800
  20. Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity.
    J Neurosci. 2004 Dec 8;24(49):11017-22 PMID: 15590917
  21. Different underlying impairments in decision-making following ventromedial and dorsolateral frontal lobe damage in humans.
    Cereb Cortex. 2005 Jan;15(1):58-63 PMID: 15217900
  22. Dissociable functions in the medial and lateral orbitofrontal cortex: evidence from human neuroimaging studies.
    Cereb Cortex. 2000 Mar;10(3):308-17 PMID: 10731225
  23. Decision-making in mania: a PET study.
    Brain. 2001 Dec;124(Pt 12):2550-63 PMID: 11701607
  24. Investigating the neurocognitive deficits associated with chronic drug misuse.
    Curr Opin Neurobiol. 2001 Apr;11(2):250-7 PMID: 11301247
  25. Addiction changes orbitofrontal gyrus function: involvement in response inhibition.
    Neuroreport. 2001 Aug 8;12(11):2595-9 PMID: 11496155
  26. Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects.
    Neuropsychopharmacology. 2002 Jan;26(1):53-63 PMID: 11751032
  27. Choosing between small, likely rewards and large, unlikely rewards activates inferior and orbital prefrontal cortex.
    J Neurosci. 1999 Oct 15;19(20):9029-38 PMID: 10516320
  28. From neurobiology to treatment: progress against addiction.
    Nat Neurosci. 2002 Nov;5 Suppl:1076-9 PMID: 12403990
  29. Addiction motivation reformulated: an affective processing model of negative reinforcement.
    Psychol Rev. 2004 Jan;111(1):33-51 PMID: 14756584
  30. Emotion, decision making and the orbitofrontal cortex.
    Cereb Cortex. 2000 Mar;10(3):295-307 PMID: 10731224
  31. Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels.
    Am J Psychiatry. 1999 Sep;156(9):1440-3 PMID: 10484959
  32. Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons.
    Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):11202-7 PMID: 8855333
  33. Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors.
    J Pharmacol Exp Ther. 1999 Oct;291(1):409-15 PMID: 10490931
  34. Storage and executive processes in the frontal lobes.
    Science. 1999 Mar 12;283(5408):1657-61 PMID: 10073923
  35. Factor structure of the Barratt impulsiveness scale.
    J Clin Psychol. 1995 Nov;51(6):768-74 PMID: 8778124
  36. Drug driving among injecting drug users in Sydney, Australia: prevalence, risk factors and risk perceptions.
    Addiction. 2004 Feb;99(2):175-85 PMID: 14756710
  37. Frontal cortical tissue composition in abstinent cocaine abusers: a magnetic resonance imaging study.
    Neuroimage. 2003 Jul;19(3):1095-102 PMID: 12880835
  38. Decreases in dopamine receptors but not in dopamine transporters in alcoholics.
    Alcohol Clin Exp Res. 1996 Dec;20(9):1594-8 PMID: 8986209
  39. Thresholding of statistical maps in functional neuroimaging using the false discovery rate.
    Neuroimage. 2002 Apr;15(4):870-8 PMID: 11906227
  40. Decision-making in a risk-taking task: a PET study.
    Neuropsychopharmacology. 2002 May;26(5):682-91 PMID: 11927193
  41. Functional neuroimaging of psychiatric disorders: exploring hidden behaviour.
    Psychol Med. 2004 May;34(4):577-81 PMID: 15099412
  42. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli.
    Psychopharmacology (Berl). 1999 Oct;146(4):373-90 PMID: 10550488
  43. Practice-related functional activation changes in a working memory task.
    Microsc Res Tech. 2000 Oct 1;51(1):54-63 PMID: 11002353
  44. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex.
    Am J Psychiatry. 2001 Dec;158(12):2015-21 PMID: 11729018
  45. Hepatitis C virus seroconversion among young injection drug users: relationships and risks.
    J Infect Dis. 2002 Dec 1;186(11):1558-64 PMID: 12447730
  46. Drug abusers show impaired performance in a laboratory test of decision making.
    Neuropsychologia. 2000;38(8):1180-7 PMID: 10838152
  47. Emotion, olfaction, and the human amygdala: amygdala activation during aversive olfactory stimulation.
    Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):4119-24 PMID: 9108115
  48. Contributions of the prefrontal cortex to the neural basis of human decision making.
    Neurosci Biobehav Rev. 2002 Oct;26(6):631-64 PMID: 12479840
  49. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine.
    Eur J Neurosci. 1999 May;11(5):1598-604 PMID: 10215912
  50. Alcohol and other drug use in occupational fatalities.
    J Occup Med. 1991 Apr;33(4):496-500 PMID: 2037904
  51. Neurobiology of addiction and implications for treatment.
    Br J Psychiatry. 2003 Feb;182:97-100 PMID: 12562734
  52. Decision making by methamphetamine-dependent subjects is associated with error-rate-independent decrease in prefrontal and parietal activation.
    Biol Psychiatry. 2003 Jan 1;53(1):65-74 PMID: 12513946
  53. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine.
    J Neurosci. 1997 Nov 1;17(21):8491-7 PMID: 9334421
  54. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms.
    Neuropsychopharmacology. 1999 Apr;20(4):322-39 PMID: 10088133
  55. Brain blood flow measured with intravenous H2(15)O. II. Implementation and validation.
    J Nucl Med. 1983 Sep;24(9):790-8 PMID: 6604140
  56. Drug addiction: bad habits add up.
    Nature. 1999 Apr 15;398(6728):567-70 PMID: 10217139
  57. Distinct portions of anterior cingulate cortex and medial prefrontal cortex are activated by reward processing in separable phases of decision-making cognition.
    Biol Psychiatry. 2004 Mar 15;55(6):594-602 PMID: 15013828
  58. The neuropsychology of ventral prefrontal cortex: decision-making and reversal learning.
    Brain Cogn. 2004 Jun;55(1):41-53 PMID: 15134842
Article Info
Journal
Psychopharmacology
Abbr.
Psychopharmacology (Berl)
ISSN
0033-3158
Published
2005-08-00
Epub
2005-00-14
Pages
612-23
Language
English
Region
Germany
NLM ID
7608025
PMCID
PMC3664787
Subset
IM
Grants
Wellcome Trust · 019407 · United Kingdom
Wellcome Trust · 064351 · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]